The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations.

Abstract excerpt

Children with steroid-resistant nephrotic syndrome secondary to WT1-associated glomerulopathies (WT1-GP) were considered unresponsive to cyclosporin A (CsA). This assumption is challenged by the findings of recent studies. The patients of these studies had different types of WT1 mutations and varying clinical presentations. However, all of them were of young age and the favourable response to CsA might be the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Angiotensin-Converting Enzyme Inhibitors
• Share to Cyclosporine